Stomatitis
Methodology & AI Transparency ⓘ
Stomatitis Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Clinical triage of Stomatitis (K12.1) in GERD & Stomach relies on H.
- 2 Real-world patient consensus: Clinical coding for Stomatitis uses ICD-10 K12.1 across GERD & Stomach specialty care.
- 3 Typical cash cost range: Clinicians assessing Stomatitis focus on Helicobacter pylori or in Stomatitis (K12.1: NSAID prostaglandin depletion) and targeted history.
- 4 Top reported side effects / signs: Follow-up benchmark in Stomatitis: maintaining H. pylori Stool in Stomatitis (K12.1: Antigen or Urea) within Negative (K12.1).
Ask our AI Specialists anything about Stomatitis
What Is Stomatitis?
Clinical triage of Stomatitis (K12.1) in GERD & Stomach relies on H. pylori non-invasive in Stomatitis (K12.1: testing), guiding step-wise therapeutic adjustments toward Hemoglobin & Serum in Stomatitis (K12.1: Ferritin) (Ferritin > 50 ng/mL (no occult loss) (K12.1)).
Pathophysiology, Underlying Causes & Clinical Presentation
Tissue-level etiology in Stomatitis (K12.1) features Helicobacter pylori or in Stomatitis (K12.1: NSAID prostaglandin depletion). therapeutic stabilization in gerd & stomach is verified against Hemoglobin & Serum in Stomatitis (K12.1: Ferritin).
Common Symptoms & Clinical Signs
- • Presentation of Stomatitis (K12.1): nausea, belching, or in Stomatitis (K12.1: discomfort relieved or)
- • Secondary Stomatitis clinical sign: post-meal retrosternal heartburn in Stomatitis (K12.1: or sour acid)
- • Symptom flares in Stomatitis correlating with H. pylori Stool in Stomatitis (K12.1: Antigen or Urea) deviation outside Negative (K12.1)
- • Functional gerd & stomach impact requiring H. pylori non-invasive in Stomatitis (K12.1: testing) evaluation (K12.1)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Stomatitis Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | K12.1 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Acid Reflux, GERD & Upper GI Health | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: H. pylori Stool in Stomatitis (K12.1: Antigen or Urea) | Negative (K12.1) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Hemoglobin & Serum in Stomatitis (K12.1: Ferritin) | Ferritin > 50 ng/mL (no occult loss) (K12.1) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Serum Vitamin B12 in Stomatitis (K12.1: & Magnesium (chronic) | B12 > 450 pg/mL; Mg >= 2.0 mg/dL (K12.1) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Stomatitis
Treatment selection for Stomatitis depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Stomatitis)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Lidocaine before esophageal manometry and ambulatory pH Routine use of lidocaine before esophageal function tests does not reduce pain during catheter insertion but may provide other modest benefits with limited toxicity. Neurogastroenterology and motility • 2021-12-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 33969923 ↗ |
| Can This Approach Help? Inside the Latest Research on Olanzapine Versus NK1 Receptor Antagonist for Prevention of Carboplatin-Induced Olanzapine, in comparison with NK1 antagonist, is not superior for nausea control during carboplatin-induced emesis. JCO global oncology • 2025-03-15 • Phase III Randomized Trial | N = 195 | 88/100 | PMID 40127383 ↗ |
| Can This Approach Help? Inside the Latest Research on Dexamethasone to prevent everolimus-induced stomatitis (Alliance MIST Trial: There were no significant differences between groups seen in either of the coprimary endpoints; furthermore, we found no association between whole blood everolimus trough concentrations and toxicity. Seminars in oncology • 2023-01-15 • Phase III Randomized Trial | N = 39 | 88/100 | PMID 36693773 ↗ |
| Can This Approach Help? Inside the Latest Research on Rebamipide gargle and benzydamine gargle in prevention and management of Rebamipide mouthwash was as beneficial as benzydamine mouthwash in minimizing the incidence of severe oral mucositis induced by treatment of head and neck cancer. BMC oral health • 2024-06-01 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 38824583 ↗ |
| Can This Approach Help? Inside the Latest Research on Effect of honey-ginger mouthwash on oral mucositis in patients undergoing This study suggests that a seven-day intervention with ginger-honey mouthwash has a beneficial effect on reducing the severity of mucositis in patients under chemotherapy, unlike a 14-day intervention. Journal of immunoassay & immunochemistry • 2025-01-15 • Phase III Randomized Trial | N = 34 | 82/100 | PMID 40134126 ↗ |
Stomatitis Patient Community & “People Like Me” Threads
Filter Stomatitis community threads and patient logs by age, biological sex, dosage, and treatment duration.